H. Shaw Warren, M.D.is an Associate Professor at Harvard Medical School, and is a Physician and Pediatrician at Massachusetts General Hospital in Boston, where he has been on staff since 1986 as a member of the Infectious Disease Unit. He is also a member of the Medical and Scientific Staff of the Shriners Burns Institute. Dr. Warren graduated from Harvard College in 1973 and Harvard Medical School in 1978. He trained in Infectious Diseases at the Beth Israel Hospital and received further research training at the Dana Farber Cancer Center before doing post-graduate work for three years in the department of Experimental Immunotherapy at the Institute Pasteur, during which time he was supported by a Fulbright Fellowship and then a Mosely Fellowship from Harvard Medical School. He then returned to work at the Massachusetts General Hospital, where he has run a laboratory in the area of host response and inflammation for 25 years. Dr. Warren has been a Consultant, Special Government Employee, Food and Drug Administration (FDA) Center for Biologics Evaluation and Research since 2001, and has been an ad hoc reviewer for a multiple different NIH study sessions, as well as for the Canadian Medical Council and The Netherlands Center for Translational Molecular Medicine (CTMM). He currently sits on the Executive and Steering Committees of the NIH Glue Grant- Inflammation and the Host Response to Injury. Dr. Warren has been a fellow of the Infectious Disease Society of America since 1989. He was co-founder of Critical Therapeutics, Inc in 1998 which became a public company in 2003 (CXTX), and was co-founder of Setpoint Medical, Inc in 2006, and is a member of multiple Scientific and Clinical Advisory Boards for small and large biotechnology companies. Dr. Warren brings broad and practical expertise in experimental and translational immunotherapy to VIC.